Literature DB >> 15290919

The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research.

Daniel W Hommes1, Gerben Sterringa, Sander J H van Deventer, Guido N J Tytgat, Jan Weel.   

Abstract

During recent years, a clear association between complicated courses of ulcerative colitis and the presence of cytomegalovirus (CMV) has been established. The exact pathogenic role of CMV in these patients remains unclear despite a great number of published reports. Therefore, we undertook a systematic review to appraise critically all available evidence in the literature on the role of CMV during inflammatory bowel disease. We identified and analyzed more than 30 case reports and 9 case series. Based on these results, we propose a model for viral replication during inflammation and provide recommendations for future research.

Entities:  

Mesh:

Year:  2004        PMID: 15290919     DOI: 10.1097/00054725-200405000-00011

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  46 in total

1.  Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital.

Authors:  Raed Al-Zafiri; Adrian Gologan; Polymnia Galiatsatos; Andrew Szilagyi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

Authors:  Tadayuki Kou; Hiroshi Nakase; Hiroyuki Tamaki; Toyoichiro Kudo; Akiyoshi Nishio; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

3.  Cytomegalovirus colitis in children with inflammatory bowel disease.

Authors:  B Ghidini; M Bellaiche; D Berrebi; J Viala; J P Hugot; J F Mougenot; A Munck; M Peuchmaur; J P Cezard
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

4.  CMV in moderately active colitis: much ado about nothing?

Authors:  Alan C Moss
Journal:  Dig Dis Sci       Date:  2010-04       Impact factor: 3.199

Review 5.  [Nonbacterial colitides].

Authors:  D E Aust; G B Baretton
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

6.  Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?

Authors:  Nina Zidar; Katja Tepeš
Journal:  Am J Gastroenterol       Date:  2016-11       Impact factor: 10.864

7.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease.

Authors:  Karen Chase Lencioni; Audrey Seamons; Piper M Treuting; Lillian Maggio-Price; Thea Brabb
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

9.  Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID).

Authors:  I Chua; R Standish; S Lear; M Harbord; E Eren; M Raeiszadeh; S Workman; D Webster
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

10.  Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Authors:  Rachele Ciccocioppo; Francesca Racca; Luigia Scudeller; Antonio Piralla; Pietro Formagnana; Lodovica Pozzi; Elena Betti; Alessandro Vanoli; Roberta Riboni; Peter Kruzliak; Fausto Baldanti; Gino Roberto Corazza
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.